Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Finasteride reduces new brain cells in male mice, possibly causing depression.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Finasteride can cause sexual problems and depression in young men.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Graying hair happens due to aging and might be delayed by new treatments.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.